Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBiocon

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Short Biocon, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may short Biocon as the stock may head lower.

    • Sell Ranbaxy, OBC, Biocon, Canara Bank: Pankaj Jain

      Pankaj Jain of Sunteck Wealthmax suggests selling Canara Bank for a target price of Rs 237 Oriental Bank of Commerce for a target price of Rs 181.

    • Bull's Eye: Sell ICICI Bank, HDIL, Ranbaxy, Biocon

      Kunal Bothra of LKP advises selling Bata India for a target price of Rs 938 and HDIL for a target price of Rs 45.50.

    • Hold Biocon, may test Rs 474: Shardul Kulkarni

      According to Shardul Kulkarni of Angel Broking, one may hold Biocon with a stoploss of Rs 435.

    • Here's why these top 10 stocks should be on your radar

      The research desk at CNBC-TV18 gives a wrap on the reason to watch out for stocks like HDFC, Infosys, L&T, Raymond, Amara Raja, Biocon, M&M Financials, KPIT Technologies, Radico Khaitan and Coromandel Engineering

    • Remain invested in Biocon: SP Tulsian

      SP Tulsian of sptulsian.com advises to remain invested in Biocon.

    • Top 10 stocks that should be on one's radar

      Top 10 stocks on CNBC-TV18's radar are Reliance Industries, oil marketing cos, United Spirits, Hindustan Zinc, Aurobindo Pharma, Biocon, Sasken, Wipro, Coal India, Reliance Mediaworks.

    • Buy Biocon; may test Rs 510-520: Rahul Mohindar

      Rahul Mohindar of Viratechindia.com advises buying Biocon at current level as the stock may test Rs 510-520.

    • Buy Biocon, CESC; sell Dish TV, SAIL: Krish Subramanium

      Krish Subramanium of Asit C Mehta Investment recommends buying CESC for a target of Rs 472 and advises selling Steel Authority of India with a target of Rs 61.50.

    • Bull's Eye: Buy Apollo Tyres, Biocon, Idea, YES Bank

      Krish Subramanium of Asit C Mehta Investment advises buying Biocon for a target price of Rs 485 and CESC for a target price of Rs 472.

    • Go long in Biocon: Ashish Chaturmohta

      Ashish Chaturmohta of Fortune Equity Broker is of the view that one may go long in Biocon at the current levels as the stock may go above Rs 500.

    • Buy Biocon, Tata Motors (DVR), HDFC: Manav Chopra

      Manav Chopra of Nirmal Bang recommends buying Housing Development Finance Corporation for a target of Rs 845 and Tata Motors (DVR) for a target of Rs 200.

    • Bull's Eye: Buy Delta Corp, Biocon, HDFC, SKS Microfinance

      Krish Subramanium of Asit C Mehta Investment advises buying Liberty Shoes for a target price of Rs 159 and Helios and Matheson for a target price of Rs 127.50.

    • Go long on Biocon, says SP Tulsian

      SP Tulsian of sptulsian.com is of the view that one may go long on Biocon with a target of Rs 480.

    • Buy Andhra Bank, Biocon, Indiabulls Real: Meghana Malkan

      Meghana Malkan of malkansview.com recommends buying Indiabulls Real Estate with a target of Rs 76 and Biocon with a target of Rs 482.

    • KR Bharat bullish on IT, healthcare, auto ancillary space

      KR Bharat, MD of Advent Advisors is bullish on IT, healthcare and auto ancillary sectors.

    • Biocon may slip to Rs 436, says SP Tulsian

      SP Tulsian of sptulsian.com feels that Biocon may slip by Rs 20 to Rs 436.

    • Buy Biocon on declines: Shardul Kulkarni

      Shardul Kulkarni of Angel Broking recommends buying Biocon on every declines.

    • Buy Biocon, Titan, Anant Raj, Geometric: Shahina Mukadam

      Shahina Mukadam of Varun Capital recommends buying Biocon for a target of Rs 396 and Titan Company for a target of Rs 230.

    • Bull's Eye: Buy Tech Mahindra, Titan, TNPL, Apollo Tyres

      Ashish Kapur of Investshoppe advises buying Tech Mahindra for a target price of Rs 1,795 and Apollo Tyres for a target price of Rs 87.

    • Exit TCS, says Hemen Kapadia

      Hemen Kapadia of KR Choksey Securities is of the view that one may exit Tata Consultancy Services (TCS).

    • Buy Tata Global, Godrej Industries, UPL, Biocon: Merani

      Nooresh Merani of AMSEC Research recommends buying UPL for a target of Rs 180 and Biocon for a target of Rs 410.

    • Bull's Eye: Buy Siemens, Tata Global, BGR Energy, UPL

      Nooresh Merani of AMSEC Research advises buying Tata Global Beverage for a target price of Rs 155 and Godrej Industries for a target price of Rs 290.

    • Buy Rallis India, PTC India, Biocon, UPL: Nooresh Merani

      According to Nooresh Merani of AMSEC Research, one may buy Rallis India with a target of Rs 185 and PTC India with a target of Rs 65.

    • Bull's Eye: Buy Rallis, Biocon, HDIL, Idea Cellular

      Nooresh Merani of AMSEC Research recommends buying Rallis India with a target of Rs 185 and Biocon with a target of Rs 400.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347